scholarly article | Q13442814 |
P50 | author | David Elashoff | Q78006947 |
David Wong | Q91719683 | ||
P2093 | author name string | Lei Zhang | |
Hui Zhou | |||
Hua Xiao | |||
David Chia | |||
Edward B Garon | |||
No-Hee Park | |||
Jay M Lee | |||
Jieping Yang | |||
Ole Brinkmann | |||
Xinmin Yan | |||
Silverio Santiago | |||
David Akin | |||
P2860 | cites work | The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects | Q21245477 |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT) | Q24308771 | ||
A small-cell lung cancer genome with complex signatures of tobacco exposure | Q24600510 | ||
Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human | Q24648354 | ||
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 | ||
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib | Q27824829 | ||
Cancer statistics, 2010 | Q27860525 | ||
Facile detection of mitochondrial DNA mutations in tumors and bodily fluids | Q28138849 | ||
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 | ||
Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer | Q28743801 | ||
Lung cancer | Q29615473 | ||
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer | Q30419853 | ||
PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. | Q30658074 | ||
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors | Q33263277 | ||
Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer | Q33466073 | ||
Electrochemical sensor for multiplex biomarkers detection | Q33563305 | ||
Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids | Q33563321 | ||
Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer | Q33699291 | ||
Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome | Q33798937 | ||
Salivary proteomics for oral cancer biomarker discovery | Q33879157 | ||
Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer | Q33983853 | ||
Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry | Q34077576 | ||
Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. | Q34396094 | ||
Salivary diagnostics powered by nanotechnologies, proteomics and genomics | Q34506558 | ||
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression | Q34555832 | ||
Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening | Q34723975 | ||
Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. | Q34766151 | ||
Effects of cigarette smoke on the human airway epithelial cell transcriptome | Q35971573 | ||
Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature | Q36217980 | ||
A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers | Q36441730 | ||
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design | Q36936929 | ||
The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment | Q37489930 | ||
Salivary biomarkers for clinical applications. | Q37587993 | ||
Diagnostic potential of saliva: current state and future applications | Q37850622 | ||
Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma | Q40141195 | ||
Proteomics and its applications for biomarker discovery in human saliva | Q41788487 | ||
What does PLIER really do? | Q41911074 | ||
NCBI GEO standards and services for microarray data. | Q43080532 | ||
EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases | Q45025171 | ||
Salivary transcriptome diagnostics for oral cancer detection | Q46169637 | ||
RNA profiling of cell-free saliva using microarray technology | Q46759712 | ||
Characterization of RNA in saliva. | Q51231347 | ||
The early identification of lung carcinoma by sputum cytology. | Q52069304 | ||
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. | Q53331692 | ||
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer | Q57077976 | ||
Sputum Trace Metals Are Biomarkers of Inflammatory and Suppurative Lung Disease | Q57416181 | ||
Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Q58053698 | ||
Reduced FEZ1/LZTS1 Expression and Outcome Prediction in Lung Cancer | Q59287273 | ||
Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR | Q73695495 | ||
Lack of association between sputum atypia and chronic obstructive pulmonary disease mortality | Q80100716 | ||
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE | Q82857174 | ||
Angiogenic markers in breath condensate identify non-small cell lung cancer | Q84331942 | ||
P433 | issue | 19 | |
P921 | main subject | lung cancer | Q47912 |
saliva | Q155925 | ||
transcriptome | Q252857 | ||
biomarker | Q864574 | ||
P304 | page(s) | 3341-3350 | |
P577 | publication date | 2012-06-12 | |
P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
P1476 | title | Development of transcriptomic biomarker signature in human saliva to detect lung cancer | |
P478 | volume | 69 |
Q64235615 | A New Approach for the Diagnosis of Systemic and Oral Diseases Based on Salivary Biomolecules |
Q88524890 | A molecular multi-gene classifier for disease diagnostics |
Q34363475 | A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype |
Q34659915 | A review of research on salivary biomarkers for oral cancer detection |
Q28264905 | AKAP4 is a circulating biomarker for non-small cell lung cancer |
Q58733994 | Alterations of fecal bacterial communities in patients with lung cancer |
Q92669414 | Atypical cyclins: the extended family portrait |
Q34840130 | Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era |
Q28066265 | Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity |
Q38909245 | Cellular identity at the single-cell level |
Q38851991 | Circular RNA: an emerging key player in RNA world |
Q36316009 | Clinical potential of gene mutations in lung cancer |
Q89809770 | Combined use of circulating tumor cells and salivary mRNA to detect non-small-cell lung cancer |
Q92367583 | Combined use of salivary biomarkers and carcinoembryonic antigen for lung cancer detection in a Chinese population |
Q64119450 | Detection of early lung cancer among military personnel (DECAMP) consortium: study protocols |
Q34513049 | Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva |
Q52898234 | Direct saliva transcript analysis as a novel non-invasive method for oestrus marker detection in buffaloes. |
Q41811785 | Discovery and validation of potential bacterial biomarkers for lung cancer |
Q64229181 | Epigallocatechin‑3‑gallate modulates long non‑coding RNA and mRNA expression profiles in lung cancer cells |
Q36810202 | Facile preparation of salivary extracellular vesicles for cancer proteomics. |
Q37656246 | Great expectorations: the potential of salivary 'omic' approaches in neonatal intensive care |
Q26700048 | Human Saliva Collection Devices for Proteomics: An Update |
Q35809192 | Identification of urine protein biomarkers with the potential for early detection of lung cancer |
Q26798564 | Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression? |
Q38238438 | Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers |
Q35672964 | Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters |
Q40077721 | Microbiota dysbiosis in select human cancers: Evidence of association and causality |
Q44201624 | More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers |
Q35585721 | Non-coding RNAs in saliva: emerging biomarkers for molecular diagnostics |
Q43463127 | Novel approaches for bioinformatic analysis of salivary RNA Sequencing data in the biomarker development process |
Q87895149 | Oral Health: The Need for Both Conventional Microbial and Molecular Characterization |
Q57788655 | Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alterations in patients with head and neck cancer |
Q26738539 | Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer |
Q37747010 | Saliva Liquid Biopsy for Point-of-Care Applications |
Q38788831 | Saliva diagnostics - Current views and directions |
Q46751395 | Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity |
Q45956385 | Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva. |
Q27024161 | Saliva-based biosensors: noninvasive monitoring tool for clinical diagnostics |
Q64120390 | Salivary Exosomes as Nanocarriers for Cancer Biomarker Delivery |
Q36632967 | Salivary biomarker development using genomic, proteomic and metabolomic approaches |
Q33777050 | Salivary biomarkers and proteomics: future diagnostic and clinical utilities |
Q33683154 | Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances |
Q89628995 | Salivary biomarkers for diagnosis of systemic diseases and malignant tumors. A systematic review |
Q39036176 | Salivary biomarkers in cancer detection |
Q37588116 | Salivary diagnostics: a brief review |
Q40085114 | Salivary extracellular RNA biomarkers for insulin resistance detection in hispanics |
Q35394619 | Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics |
Q38601695 | Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases. |
Q99582777 | Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion |
Q50047837 | Significance of blood and salivary IEX-1 expression in diagnosis of epithelial ovarian carcinoma |
Q49791858 | The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection |
Q38673801 | The Neonatal Salivary Transcriptome |
Q47115593 | The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor |
Q34424468 | The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics |
Q38667953 | The emerging landscape of salivary diagnostics. |
Q35096347 | The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva |
Q38335053 | Translating the transcriptome into tools for the early detection and prevention of lung cancer |
Q36076092 | Validation of Reference Genes for Oral Cancer Detection Panels in a Prospective Blinded Cohort |
Search more.